1. Report on Vital Statistics, 1987. Central Statistics Office, Dublin, 1990.
2. Gruppo Italiano Per Lo Studio Delia Streptochinasi Nell ’ Infarto Miocardio (GISSI). Effectiveness of intravenous thrombolytic therapy in acute myocardial infarction. Lancet 1986: 1, 397–402.
3. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988: 2, 349–60.
4. Wilcox, R. G., von der Lippe, G., Olsson, C. G.et al. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988: 2, 525–530.
5. Rawles, J. M., Haites, N. E. Patient and general practitioner delays in acute myocardial infarction. BMJ 1988: 296, 882–884.